KHTRF - Knight Therapeutics Inc. (KHTRF) Q2 2025 Earnings Call Transcript

2025-08-08 01:23:30 ET

Knight Therapeutics Inc. (KHTRF)

Q2 2025 Earnings Conference Call

August 07, 2025, 8:30 AM ET

Company Participants

Amal Khouri - Chief Business Officer

Arvind Utchanah - Chief Financial Officer

Samira Sakhia - President, CEO & Director

Conference Call Participants

David C. Martin - Bloom Burton & Co., Research Division

Michael W. Freeman - Raymond James Ltd., Research Division

Sahil Dhingra - RBC Capital Markets, Research Division

Presentation

Operator

Good morning, ladies and gentlemen. My name is Sergio, and I will be your operator today. Welcome to Knight Therapeutics Second Quarter 2025 Results Conference Call. Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements....

For further details see: